A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa

Clinical trial NCT00869791 · COMPLETED

Trial details

NCT number: NCT00869791
Sponsor: Impax Laboratories, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2008-11-01
Primary completion: 2009-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.